{"id":6515,"date":"2021-12-27T10:15:12","date_gmt":"2021-12-27T10:15:12","guid":{"rendered":"https:\/\/riberasalud.com\/povisa\/?post_type=povisaenmedios&amp;p=6515"},"modified":"2021-12-27T10:15:12","modified_gmt":"2021-12-27T10:15:12","slug":"faro-vigo-de-la-fuente-monoclonales","status":"publish","type":"post","link":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/","title":{"rendered":"De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"\n<p>\u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra en los primeros momentos de la infecci\u00f3n\u201d, explica el doctor\u00a0<strong>Javier de la Fuente Aguado<\/strong>, jefe de Medicina Interna del hospital vigu\u00e9s Ribera-Povisa y presidente de la Sociedad Gallega de Medicina Interna (SOGAMI). Constituyen, por tanto, un importante aliado para tratar la enfermedad que causa el SARS-CoV-2. Lo ha contado en una entrevista en <a href=\"https:\/\/www.farodevigo.es\/sociedad\/2021\/12\/26\/anticuerpos-monoclonales-reducen-necesidad-hospitalizacion-61028409.html\">Faro de Vigo<\/a> que tambi\u00e9n ha recogido La Opini\u00f3n de A Coru\u00f1a.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\" alt=\"\" class=\"wp-image-6516\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.40-759x1024.png\" alt=\"\" class=\"wp-image-6517\"\/><\/figure>\n\n\n\n<p><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"<p>\u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra en los primeros momentos de la infecci\u00f3n\u201d, explica el doctor\u00a0Javier de la Fuente Aguado, jefe de Medicina Interna del hospital vigu\u00e9s Ribera-Povisa y presidente de la Sociedad Gallega de Medicina &#8230; <a title=\"De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d\" class=\"read-more\" href=\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\" aria-label=\"Leer m\u00e1s sobre De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d\">Leer m\u00e1s<\/a><\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6515","post","type-post","status-publish","format-standard","hentry","category-sin-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa<\/title>\n<meta name=\"description\" content=\"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 &quot;Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI&quot;, ha contado el Dr. De la Fuente en Faro de Vigo\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa\" \/>\n<meta property=\"og:description\" content=\"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 &quot;Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI&quot;, ha contado el Dr. De la Fuente en Faro de Vigo\" \/>\n<meta property=\"og:url\" content=\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\" \/>\n<meta property=\"og:site_name\" content=\"Hospital Ribera Povisa\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-27T10:15:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\" \/>\n<meta name=\"author\" content=\"comunicacion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"comunicacion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\"},\"author\":{\"name\":\"comunicacion\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/a86021b8be1af47eab6013c92aef8cb2\"},\"headline\":\"De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d\",\"datePublished\":\"2021-12-27T10:15:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\"},\"wordCount\":115,\"publisher\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/#organization\"},\"image\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\",\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\",\"url\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\",\"name\":\"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa\",\"isPartOf\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\",\"datePublished\":\"2021-12-27T10:15:12+00:00\",\"description\":\"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 \\\"Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\\\", ha contado el Dr. De la Fuente en Faro de Vigo\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage\",\"url\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\",\"contentUrl\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#website\",\"url\":\"https:\/\/riberasalud.com\/povisa\/\",\"name\":\"Hospital Ribera Povisa\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/riberasalud.com\/povisa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#organization\",\"name\":\"Hospital Ribera Povisa\",\"url\":\"https:\/\/riberasalud.com\/povisa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2024\/01\/cropped-Logo-Red-Povisa.png\",\"contentUrl\":\"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2024\/01\/cropped-Logo-Red-Povisa.png\",\"width\":1929,\"height\":489,\"caption\":\"Hospital Ribera Povisa\"},\"image\":{\"@id\":\"https:\/\/riberasalud.com\/povisa\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/a86021b8be1af47eab6013c92aef8cb2\",\"name\":\"comunicacion\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/60cbbba75f9dfb772d5274ba6ef24949409430d363a66afa01a67aac15877cc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/60cbbba75f9dfb772d5274ba6ef24949409430d363a66afa01a67aac15877cc8?s=96&d=mm&r=g\",\"caption\":\"comunicacion\"},\"url\":\"https:\/\/riberasalud.com\/povisa\/author\/comunicacion\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa","description":"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 \"Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\", ha contado el Dr. De la Fuente en Faro de Vigo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/","og_locale":"es_ES","og_type":"article","og_title":"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa","og_description":"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 \"Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\", ha contado el Dr. De la Fuente en Faro de Vigo","og_url":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/","og_site_name":"Hospital Ribera Povisa","article_published_time":"2021-12-27T10:15:12+00:00","og_image":[{"url":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png","type":"","width":"","height":""}],"author":"comunicacion","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"comunicacion","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#article","isPartOf":{"@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/"},"author":{"name":"comunicacion","@id":"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/a86021b8be1af47eab6013c92aef8cb2"},"headline":"De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d","datePublished":"2021-12-27T10:15:12+00:00","mainEntityOfPage":{"@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/"},"wordCount":115,"publisher":{"@id":"https:\/\/riberasalud.com\/povisa\/#organization"},"image":{"@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage"},"thumbnailUrl":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png","inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/","url":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/","name":"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa","isPartOf":{"@id":"https:\/\/riberasalud.com\/povisa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage"},"image":{"@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage"},"thumbnailUrl":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png","datePublished":"2021-12-27T10:15:12+00:00","description":"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 \"Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\", ha contado el Dr. De la Fuente en Faro de Vigo","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/#primaryimage","url":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png","contentUrl":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png"},{"@type":"WebSite","@id":"https:\/\/riberasalud.com\/povisa\/#website","url":"https:\/\/riberasalud.com\/povisa\/","name":"Hospital Ribera Povisa","description":"","publisher":{"@id":"https:\/\/riberasalud.com\/povisa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/riberasalud.com\/povisa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/riberasalud.com\/povisa\/#organization","name":"Hospital Ribera Povisa","url":"https:\/\/riberasalud.com\/povisa\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/riberasalud.com\/povisa\/#\/schema\/logo\/image\/","url":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2024\/01\/cropped-Logo-Red-Povisa.png","contentUrl":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2024\/01\/cropped-Logo-Red-Povisa.png","width":1929,"height":489,"caption":"Hospital Ribera Povisa"},"image":{"@id":"https:\/\/riberasalud.com\/povisa\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/a86021b8be1af47eab6013c92aef8cb2","name":"comunicacion","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/riberasalud.com\/povisa\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/60cbbba75f9dfb772d5274ba6ef24949409430d363a66afa01a67aac15877cc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/60cbbba75f9dfb772d5274ba6ef24949409430d363a66afa01a67aac15877cc8?s=96&d=mm&r=g","caption":"comunicacion"},"url":"https:\/\/riberasalud.com\/povisa\/author\/comunicacion\/"}]}},"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/posts\/6515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/comments?post=6515"}],"version-history":[{"count":0,"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/posts\/6515\/revisions"}],"wp:attachment":[{"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/media?parent=6515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/categories?post=6515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/riberasalud.com\/povisa\/wp-json\/wp\/v2\/tags?post=6515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}